US EditionTrump Strategy to Rein In Drug Prices Revives ‘Most Favored Nation’ Plan of His First Term
- On May 13, 2025, an executive order was signed by President Donald Trump aimed at significantly reducing the cost of prescription drugs in the U.S. By implementing a most-favored-nation pricing strategy.
- This order revives a similar policy from Trump's first term that failed due to legal challenges and aims to link U.S. Drug prices to those of other developed countries.
- The policy targets nearly 150 million Medicare and Medicaid recipients, instructing drugmakers to meet price targets within 30 days or face government-imposed caps, while also promoting direct manufacturer sales.
- Trump claimed the order would reduce drug prices by 30% to 90% almost immediately, but experts anticipate significant legal and procedural obstacles similar to past efforts.
- If implemented, the order could reshape drug pricing in the U.S. But likely faces strong pharmaceutical industry opposition and uncertain impact on innovation and investment.
16 Articles
16 Articles
Trump Executive Order Seeks to Lower Drug Prices, But Offers No Means for Enforcement
President Trump signed an executive order Monday directing U.S. drugmakers to cut their prices by up to 80%. But the order does not include any enforcement mechanisms, and pharmaceutical stocks rose following the news and amid relief within the industry. In a social media post, Trump invoked his “most favored nation” plan that he unsuccessfully tried to enact in his first term, which aims to bring U.S. drug prices in line with other wealthy coun…
Trump wants to import foreign drug prices. Medicaid cuts unveiled
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. The HHS secretary on Sunday took a dip in Rock Creek — in his jeans, of course. The creek is apparently teeming with E. coli from the overflow of D.C.’s sewage system. Send fun or serious tips to John.Wilkerson@statnews.com or via Signal at John_…
Bernie says he’ll help Trump reduce prescription drug prices - Vermont Daily Chronicle
By Paul BeanPresident Donald Trump signed an executive order yesterday (5/12) implementing a “Most Favored Nation” policy that aims to align U.S. prescription drug prices with the lowest prices paid by other developed nations, potentially reducing costs between 30% and 80% on prescription drugs. Sen. Bernie Sanders immediately promised he would work with Trump to turn the EO into a law and challenged the president to get onboard when he introduc…
Trump Prescribes Deep Discounts for Big Pharma
Photo by Cj via UnsplashThis story was originally published on The Daily Upside. To receive delivering razor sharp analysis and perspective on all things finance, economics, and markets, subscribe to our free The Daily Upside newsletter.Pharma companies may need more than a spoonful of sugar to digest President Trump’s latest prescription: An executive order he said will slash US drug prices anywhere from 59% to “even 90%.” The “Most-Favored Na…
Trump Strategy to Rein In Drug Prices Revives ‘Most Favored Nation’ Plan of His First Term
President Trump’s executive order provides a framework for tying the prices of U.S. pharmaceutical products to the lower prices paid in other countries, what’s called most-favored-nation pricing. If drug companies do not lower their prices accordingly, the order proposes other strategies, such as importing drugs from other countries.
Coverage Details
Bias Distribution
- 71% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
